Pharmacokinetics and Safety of Elotuzumab Combined With Lenalidomide and Dexamethasone in Patients With Multiple Myeloma and Various Levels of Renal Impairment: Results of a Phase Ib Study

The results of the present study support the use of elotuzumab for the treatment of patients with MM and renal dysfunction without dose adjustment.